Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2

Conditions

Multiple Myeloma 26Lymphoma 22Leukemia, Myeloid, Acute 21Leukemia 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Non-Hodgkin 17Myelodysplastic Syndromes 16Hodgkin Disease 15Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Hematologic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Follicular 6Primary Myelofibrosis 5Neoplasms, Plasma Cell 5Myeloproliferative Disorders 5Recurrence 4Neuroblastoma 4Graft vs Host Disease 4Burkitt Lymphoma 4Breast Neoplasms 4Polycythemia Vera 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myelomonocytic, Juvenile 3Ganglioneuroblastoma 3Thrombocythemia, Essential 2Testicular Neoplasms 2Rhabdomyosarcoma 2

Interventions

fludarabine phosphate 15Whole-Body Irradiation 9Peripheral Blood Stem Cell Transplantation 9Mycophenolic Acid 9Cyclophosphamide 8Busulfan 8Tacrolimus 7Cyclosporine 5ruxolitinib 4fludarabine 4Methotrexate 4Antilymphocyte Serum 411-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3peginterferon alfa-2a 2givinostat hydrochloride 2givinostat 2Stem Cell Transplantation 2Radiotherapy 2Melphalan 2Etoposide 2Carboplatin 2veliparib 1thymoglobulin 1sonidegib 1pomalidomide 1merphos 1bomedemstat 1anagrelide 1Transplantation 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Thrombocythemia, Essential × Stem Cell Transplantation × Clear all
NCT03878199 2026-04-24

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

Ohio State University Comprehensive Cancer Center

Phase 1/2 Terminated
12 enrolled 15 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT02410551 2018-10-30

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡